Jamal Zidan

Summary

Country: Israel

Publications

  1. ncbi request reprint Prevention of chemotherapy-induced neutropenia by special honey intake
    Jamal Zidan
    Oncology Unit, Sieff Hospital, Safed, Israel
    Med Oncol 23:549-52. 2006
  2. ncbi request reprint Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival
    Jamal Zidan
    Oncology Unit, Sieff Government Hospital, Safed, Israel
    Cancer 97:1181-5. 2003
  3. doi request reprint Differences in pathological and clinical features of breast cancer in Arab as compared to Jewish women in Northern Israel
    Jamal Zidan
    Oncology Institute, Ziv Medical Center, Safed, Israel
    Int J Cancer 131:924-9. 2012
  4. ncbi request reprint Treating relapsed epithelial ovarian cancer with luteinizing hormone-releasing agonist (goserelin) after failure of chemotherapy
    Jamal Zidan
    Oncology Unit, Sieff Government Hospital, Safed, Israel
    Isr Med Assoc J 4:597-9. 2002
  5. pmc Ezetimibe's effect on platelet aggregation and LDL tendency to peroxidation in hypercholesterolaemia as monotherapy or in addition to simvastatin
    Osamah Hussein
    Department of Internal Medicine A, Ziv Medical Centre, Safed, Israel
    Br J Clin Pharmacol 65:637-45. 2008
  6. pmc Characteristics of common solid liver lesions and recommendations for diagnostic workup
    Nimer Assy
    Liver Unit, Ziv Medical Center, Zefat 13100, Israel
    World J Gastroenterol 15:3217-27. 2009
  7. ncbi request reprint Serum CA125: a tumor marker for monitoring response to treatment and follow-up in patients with non-Hodgkin's lymphoma
    Jamal Zidan
    Oncology Unit, Sieff Government Hospital, POB 1008, Safed, Israel
    Oncologist 9:417-21. 2004
  8. ncbi request reprint Interstitial brachytherapy in soft tissue sarcomas: the Rambam experience
    Edward Rosenblatt
    Brachytherapy Unit, Department of Oncology, Rambam Medical Center, Technion Faculty of Medicine, Haifa, Israel
    Isr Med Assoc J 5:547-51. 2003
  9. ncbi request reprint Interleukin-2, interferon-alpha, 5-fluorouracil, and vinblastine in the treatment of metastatic renal cell carcinoma: a prospective phase II study: the experience of Rambam and Lin Medical Centers 1996-2000
    Eliahu Gez
    Department of Oncology, Rambam Medical Center, Haifa, Israel
    Cancer 95:1644-9. 2002
  10. ncbi request reprint Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN)
    Hadassah Goldberg
    Division of Oncology, Rambam Health Care Campus and Rappaport Faculty of Medicine, Technion, Haifa, Israel
    Gynecol Oncol 108:298-305. 2008

Detail Information

Publications18

  1. ncbi request reprint Prevention of chemotherapy-induced neutropenia by special honey intake
    Jamal Zidan
    Oncology Unit, Sieff Hospital, Safed, Israel
    Med Oncol 23:549-52. 2006
    ..The use of LMH in patients who are at high risk of developing neutropenia as a result of chemotherapy decreases the risk of pancytopenia and the need for CSFs. LMH is inexpensive, has no side effects, and is easy to administer...
  2. ncbi request reprint Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival
    Jamal Zidan
    Oncology Unit, Sieff Government Hospital, Safed, Israel
    Cancer 97:1181-5. 2003
    ..A retrospective study was performed to identify the influence of FVPTC compared with PTC on therapeutic variables, prognostic variables, and survival...
  3. doi request reprint Differences in pathological and clinical features of breast cancer in Arab as compared to Jewish women in Northern Israel
    Jamal Zidan
    Oncology Institute, Ziv Medical Center, Safed, Israel
    Int J Cancer 131:924-9. 2012
    ..Socioeconomic factors alone are not sufficient to explain significant effects of race on tumor characteristics. Findings suggest a different genetic susceptibility in the two populations which needs further research...
  4. ncbi request reprint Treating relapsed epithelial ovarian cancer with luteinizing hormone-releasing agonist (goserelin) after failure of chemotherapy
    Jamal Zidan
    Oncology Unit, Sieff Government Hospital, Safed, Israel
    Isr Med Assoc J 4:597-9. 2002
    ..Chemical agents used for third and fourth-line therapy usually yield poor results with severe toxic side effects...
  5. pmc Ezetimibe's effect on platelet aggregation and LDL tendency to peroxidation in hypercholesterolaemia as monotherapy or in addition to simvastatin
    Osamah Hussein
    Department of Internal Medicine A, Ziv Medical Centre, Safed, Israel
    Br J Clin Pharmacol 65:637-45. 2008
    ..Statins demonstrate a pleiotropic effect which contributes beyond the hypocholesterolaemic effect to prevent atherosclerosis...
  6. pmc Characteristics of common solid liver lesions and recommendations for diagnostic workup
    Nimer Assy
    Liver Unit, Ziv Medical Center, Zefat 13100, Israel
    World J Gastroenterol 15:3217-27. 2009
    ..If the patient is known to have a primary malignancy and the lesion was found at tumor staging or follow up, histology is required only when the nature of the liver lesion is doubtful...
  7. ncbi request reprint Serum CA125: a tumor marker for monitoring response to treatment and follow-up in patients with non-Hodgkin's lymphoma
    Jamal Zidan
    Oncology Unit, Sieff Government Hospital, POB 1008, Safed, Israel
    Oncologist 9:417-21. 2004
    ..The aim of the current study is to evaluate CA125 levels in patients with NHL and to investigate the correlations between high CA125 level and other presenting features...
  8. ncbi request reprint Interstitial brachytherapy in soft tissue sarcomas: the Rambam experience
    Edward Rosenblatt
    Brachytherapy Unit, Department of Oncology, Rambam Medical Center, Technion Faculty of Medicine, Haifa, Israel
    Isr Med Assoc J 5:547-51. 2003
    ..There are radiobiologic and technical advantages to the use of interstitial brachytherapy alone or as an adjunct to external beam radiotherapy in the postoperative treatment of soft tissue sarcomas...
  9. ncbi request reprint Interleukin-2, interferon-alpha, 5-fluorouracil, and vinblastine in the treatment of metastatic renal cell carcinoma: a prospective phase II study: the experience of Rambam and Lin Medical Centers 1996-2000
    Eliahu Gez
    Department of Oncology, Rambam Medical Center, Haifa, Israel
    Cancer 95:1644-9. 2002
    ..The current study evaluated the efficacy and toxicity of interleukin-2 (IL-2), interferon-alpha (IFN-alpha), 5-fluorouracil (5-FU), and vinblastine (VBL) in the treatment of metastatic renal cell carcinoma (MRCC)...
  10. ncbi request reprint Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN)
    Hadassah Goldberg
    Division of Oncology, Rambam Health Care Campus and Rappaport Faculty of Medicine, Technion, Haifa, Israel
    Gynecol Oncol 108:298-305. 2008
    ..Uterine papillary serous carcinoma (UPSC) is a rare subtype of endometrial carcinoma, characterized by a poor outcome. We sought to better analyze the effect of surgery and adjuvant therapies on this disease...
  11. pmc Effect of letrozole on plasma lipids, triglycerides, and estradiol in postmenopausal women with metastatic breast cancer
    Jamal Zidan
    Ziv Medical Center, Safed, Israel
    Oncologist 15:1159-63. 2010
    ..The aim of this prospective study was to evaluate the effect of letrozole on plasma lipids, triglyceride lipase (TGL), and estradiol levels in women with metastatic breast cancer (MBC). Materials and..
  12. ncbi request reprint Efficacy of I131 ablation therapy using different doses as determined by postoperative thyroid scan uptake in patients with differentiated thyroid cancer
    Jamal Zidan
    Oncology Unit, Sieff Government Hospital, PO Box 1008, Safed 13100, Israel
    Int J Radiat Oncol Biol Phys 59:1330-6. 2004
    ..The current study was conducted to determine the optimal dose of I(131) for remnant postoperative ablation. A review of the literature is included...
  13. ncbi request reprint Effects of tamoxifen on bone mineral density and metabolism in postmenopausal women with early-stage breast cancer
    Jamal Zidan
    Oncology Unit, Sieff Government Hospital, Safed, Israel
    Med Oncol 21:117-21. 2004
    ..Changes in serum concentration of biochemical markers may reflect decreased bone turnover or bone remodeling and add to the understanding of tamoxifen's effect on bone mineral density...
  14. ncbi request reprint Arterial elasticity in obese subjects with coronary slow flow phenomenon
    Osamah Hussein
    Department of Internal Medicine A, Ziv Medical Center, Safed, Israel
    Isr Med Assoc J 15:753-7. 2013
    ..Coronary slow flow phenomenon (CSFP) is a functional and structural disease that is diagnosed by coronary angiogram...
  15. ncbi request reprint A novel MSH2 germline mutation in a Druze HNPCC family
    Jamal Zidan
    Oncology Unit, Rivkah Ziv Medical Center, Zefat, Israel
    Fam Cancer 7:135-9. 2008
    ..This is the first mutation ever reported in a colon cancer susceptibility gene in a Druze family and it appears not to be a founder mutation in Druze individuals with HNPCC...
  16. doi request reprint Oral premedication for the prevention of hypersensitivity reactions to paclitaxel
    Jamal Zidan
    Oncology Unit, Ziv Medical Center, POB 1008, Zefat 13100, Israel
    Med Oncol 25:274-8. 2008
    ..This strategy is feasible, gives excellent results in reducing hypersensitivity reactions and shortens the time of treatment for patients and treating staff...
  17. ncbi request reprint The 1100delAT BRCA1 and the 8765delAG BRCA2 mutations: occurrence in high-risk non-Ashkenazi Jews and haplotype comparison of Jewish and non-Jewish carriers
    Inbar Gal
    Susanne Levy Gertner Oncogenetics Unit, The Danek Gertner Institute of Genetics, Chaim Sheba Medical Center, Tel Hashomer, Israel
    Fam Cancer 3:11-4. 2004
    ....
  18. ncbi request reprint Nephrotoxicity of combined treatment with cisplatin and gentamicin in the guinea pig: glomerular injury findings
    Sarah Kohn
    Electron Microscopy Unit, The Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    Ultrastruct Pathol 26:371-82. 2002
    ....